Characterization of a Mouse Factor IX cDNA and Developmental Regulation of the Factor IX Gene Expression in Liver

Shou-Nan Yao; Audrey H DeSilva; Sumiko Kurachi; Linda C Samuelson; Kotoku Kurachi

doi:10.1055/s-0038-1647453

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1991; 65(01): 052-058
DOI: 10.1055/s-0038-1647453

Original Article

Schattauer GmbH Stuttgart

Characterization of a Mouse Factor IX cDNA and Developmental Regulation of the Factor IX Gene Expression in Liver^[*]

Authors

Shou-Nan Yao

The Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA
Audrey H DeSilva

The Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA
Sumiko Kurachi

The Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA
Linda C Samuelson

The Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA
Kotoku Kurachi

The Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA

Abstract

als PDF herunterladen

Summary

A mouse factor IX cDNA was isolated and characterrzed. The cDNA was 1,837 bp in length and contained the coding region as well as short 5’ and 3’ untranslated sequences. Northern blot analysis of liver RNA showed two mRNA species of 3.2 kb (major) and 2.2 kb (minor) for the mouse factor IX. An antisgnse RNA probe prepared from the mouse cDNA was employed to determine the steady state level of factor IX mRNA in mouse liver at various developmental stages. The factor IX mRNA level was very low (2–5% of the adult level) during the gestational period until day –3 (gestational day 17) followed by a rapid increase at day –2 through birth. This phase of rapid increase was followed by a gradual increase before it reached the adult level at around 20 to 24 days. At birth, the factor IX mRNA level was found to be at about 43% of that of the adult. The rnRNA levels in mouse liver agreed well with the plasma factor IX activity levels. These results indicate that reduced factor IX activity in newborns is due to the low levels of factor IX mRNA available for translation.

PDF (1578 kb)

Referenzen

References
1 Kurachi K, Chen S-H. Human genes for factor IX and other vitamin K dependent blood proteins. In: The New Dimension of Warfarin Prophylaxis Wesler S, Becker CG, Nemerson Y. (eds) Plenum Publishing Corp; New York: 1987: 67-81
2 Hedner U, Davie EW. Introduction to hemostasis and the vitamin Independent coagulation factor. In: The Metabolic Basis of Inherited Diseases, Vol. II. Sixth ed Scriner CR, Beaudet AL, Sly WS, Valle D. (eds) McGraw Hill; New York: 1989: 2107-2134
3 Salier JP, Hirosawa S, Kurachi K. Functional characterization of the 5’ regulatory region of human factor IX gene. J Biol Chem 1990; 265: 7062-7068
4 Kurachi K, Chen SH. Molecular genetic analysis of congenital disease: Disorders of human blood coagulation factors. In: Hematologic Diseases in Maternal-Fetal Medicine Bern MM, Frigoletto F. (eds) Alan R. Liss, Inc; New York: 1990. in press
5 Kurachi K, Davie EW. Isolation and characterization of a cDNA coding for human factor IX gene. Proc Natl Acad Sci USA 1982; 79: 6461-6464
6 Yoshitake S, Schack BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX. Biochemistry 1985; 24: 3736-3750
7 Anson DS, Choo KH, Rees D JG, Giannelli F, Gould K, Huddelston JA, Brownlee GG. The gene structure of human antihemophilic factor IX. EMBO J 1984; 3: 1053-1060
8 Jaye M, de la SalleH, Schamber F, Balland A, Kohli V, Findeli A, Tolstoshev P, Lecocq JP. Isolation of a human anti-hemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucl Acid Res 1983; 11: 2325-2335
9 Hirosawa S, Fahner JB, Salier JP, Wu CT, Lovrien EW, Kurachi K. Structural and functional basis of the developmental regulation of human coagulation factor IX gene: Factor IX-Leyden. Proc Natl Acad Sci USA 1990; 87: 4421-4425
10 Terwiel JP, Veltkamp JJ, Bertina RM, Muller HP. Coagulation factors in the human fetus of about 20 weeks of gestational age. Br J Haematol 1980; 45: 641-650
11 Schettini F, Mattia DD, Altomare M, Montagna O. Postnatal development of factor IX. Acta Paed Scand 1980; 69: 53-58
12 Thompson AR. Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis. Blood 1984; 64: 867-874
13 Forestier F, Daffos F, Rainaut M, Sole Y, Amiral J. Vitamin K dependent proteins in fetal hemostasis at mid trimester of pregnancy. Thromb Haemostas 1985; 53: 401-403
14 Andrew M, Paes B, Milner R, Johnston M, Mitchel L, Tollefsen DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172
15 Andrew M, Paes B, Milner R, Johnston M, Mitchel L, Tollefsen DM, Castle V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657
16 Kisker CT, Robillard JE, Clarke WR. Development of blood coagulation – a fetal lamb model. Paediatr Res 1981; 15: 1045-1050
17 Kisker CT, Perlman S, Bohlken D, Wicklund B. Measurement of prothrombin mRNA during gestation and early neonatal development. J Lab Clin Med 1988; 112: 407-412
18 Lane PA, Hathaway WE. Vitamin K in infancy. J Pediat 1985; 106: 351-359
19 Malia RG, Preston FE, Mitchell VE. Evidence against vitamin K deficiency in normal neonates. Thromb Haemostas 1980; 44s: 159-160
20 Bloch CA, Rothberg AD, Bradlow BA. Mother-infant prothrombin precursor status at birth. J Paediat Gastoenterol Nutr 1984; 3: 101-103
21 Benton WD, Davis RW. Screening λgt recombinant clones by hybridization to single plaques in situ. Science 1977; 196: 180-182
22 Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, Struhl K. In: Current Protocols in Molecular Biology John Wiley and Sons; New York: 1987
23 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
24 Samuelson LC, Keller PR, Darlington GJ, Meisler MH. Glucocorticoid and developmental regulation of amylase mRNA in mouse liver cells. Mol Cell Biol 1988; 8: 3857-3863
25 Sambrook J, Fritsch EF, Maniatis T. In: Molecular Cloning, A Laboratory Manual. 2nd ed Cold Spring Harbor Laboratory Press; New York: 1989: 7.37-7.52
26 Evans JP, Watzke HH, Ware JL, Stafford DW, High KA. Molecular cloning of a cDNA encoding canine factor IX. Blood 1989; 74: 207-212
27 Sarker G, Koeberl DD, Sommer SS. Direct sequencing of the activation peptide and catalytic domain of the factor IX gene in six species. Genomics 1990; 6: 133-143
28 Wu SM, Stafford DW, Ware J. Deduced amino acid sequence of mouse blood coagulation factor IX. Gene 1990; 86: 275-278
29 Katayama K, Ericsson LH, Enfield DL, Thompson CAB, Walsh KA, Neurath H, Davie EW, Titani K. Comparison of amino acid sequence of bovine coagulation factor IX (Christmas factor) with that of other vitamin-K dependent plasma proteins. Proc Natl Acad Sci USA 1979; 76: 4990-4994
30 Hassan HJ, Leonardi A, Chelucci C, Guerriero R, Mannucci PM, Peschle C. Expression in ontogenesis of human blood coagulation factors. Thromb Haemostas 1987; 58: 490
31 Thompson AR. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin and with hemophilia B. J Clin Invest 1977; 59: 900-910

Characterization of a Mouse Factor IX cDNA and Developmental Regulation of the Factor IX Gene Expression in Liver[*]

Authors

Characterization of a Mouse Factor IX cDNA and Developmental Regulation of the Factor IX Gene Expression in Liver^[*]